Profound Medical Corp. (PROF)
USD 5.0
(-6.98%)
USD 5.0
(-6.98%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4.97 Million USD | -33.39% |
| 2022 | 7.46 Million USD | 562.64% |
| 2021 | 1.12 Million USD | -17.38% |
| 2020 | 1.36 Million USD | -79.86% |
| 2019 | 6.77 Million CAD | -13.12% |
| 2018 | 7.79 Million CAD | 2108.04% |
| 2017 | 352.98 Thousand CAD | -87.38% |
| 2016 | 2.79 Million CAD | -30.17% |
| 2015 | 4 Million CAD | 105.56% |
| 2014 | 1.94 Million CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 501 Thousand USD | -100.0% |
| 2024 Q2 | 3.94 Million USD | 0.0% |
| 2023 Q3 | 5.97 Million USD | 743.22% |
| 2023 Q2 | 708 Thousand USD | -89.86% |
| 2023 Q1 | 6.98 Million USD | -6.52% |
| 2023 Q4 | 4.97 Million USD | -16.68% |
| 2023 FY | 4.97 Million USD | -33.39% |
| 2022 Q3 | 870 Thousand USD | -11.68% |
| 2022 Q2 | 985 Thousand USD | -9.22% |
| 2022 Q1 | 1.08 Million USD | -3.73% |
| 2022 FY | 7.46 Million USD | 562.64% |
| 2022 Q4 | 7.46 Million USD | 758.39% |
| 2021 Q4 | 1.12 Million USD | 8.16% |
| 2021 Q2 | 1.16 Million USD | -1.68% |
| 2021 Q1 | 1.18 Million USD | -12.9% |
| 2021 Q3 | 1.04 Million USD | -10.79% |
| 2021 FY | 1.12 Million USD | -17.38% |
| 2020 Q1 | 1.43 Million CAD | -78.8% |
| 2020 Q3 | 1.37 Million CAD | -3.0% |
| 2020 Q4 | 1.36 Million USD | -0.87% |
| 2020 FY | 1.36 Million USD | -79.86% |
| 2020 Q2 | 1.41 Million CAD | -1.22% |
| 2019 FY | 6.77 Million CAD | -13.12% |
| 2019 Q3 | 7.37 Million CAD | -10.74% |
| 2019 Q1 | 9.21 Million CAD | 18.22% |
| 2019 Q2 | 8.25 Million CAD | -10.37% |
| 2019 Q4 | 6.77 Million CAD | -8.14% |
| 2018 Q2 | - CAD | -100.0% |
| 2018 Q3 | 9.02 Million CAD | 0.0% |
| 2018 Q4 | 7.79 Million CAD | -13.66% |
| 2018 FY | 7.79 Million CAD | 2108.04% |
| 2018 Q1 | 336.98 Thousand CAD | -4.53% |
| 2017 Q1 | 1.96 Million CAD | -29.65% |
| 2017 Q2 | 1.9 Million CAD | -3.28% |
| 2017 Q4 | 352.98 Thousand CAD | -3.2% |
| 2017 Q3 | 364.64 Thousand CAD | -80.85% |
| 2017 FY | 352.98 Thousand CAD | -87.38% |
| 2016 Q1 | 4.08 Million CAD | 1.99% |
| 2016 Q2 | 3.16 Million CAD | -22.62% |
| 2016 Q4 | 2.79 Million CAD | -6.05% |
| 2016 Q3 | 2.97 Million CAD | -5.83% |
| 2016 FY | 2.79 Million CAD | -30.17% |
| 2015 Q2 | 4.26 Million CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q3 | 3.96 Million CAD | -7.04% |
| 2015 Q4 | 4 Million CAD | 1.06% |
| 2015 FY | 4 Million CAD | 105.56% |
| 2014 FY | 1.94 Million CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 86.221% |
| BrainsWay Ltd. | 239 Thousand USD | -1981.346% |
| Cerus Corporation | 59.79 Million USD | 91.681% |
| Envoy Medical, Inc. | 404 Thousand USD | -1131.292% |
| electroCore, Inc. | 537 Thousand USD | -826.335% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -41353.483% |
| IceCure Medical Ltd | 376 Thousand USD | -1222.984% |
| Inogen, Inc. | 18.27 Million USD | 72.773% |
| OrthoPediatrics Corp. | 13.45 Million USD | 63.04% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -2399.708% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -1267.635% |
| MaxCyte, Inc. | 17.96 Million USD | 72.317% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -8897.934% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 94.657% |
| PAVmed Inc | 2.96 Million USD | -68.055% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 19.948% |
| RxSight, Inc. | 1.21 Million USD | -310.769% |
| Sight Sciences, Inc. | 31.7 Million USD | 84.312% |
| SI-BONE, Inc. | 36.06 Million USD | 86.207% |
| TELA Bio, Inc. | 40.51 Million USD | 87.722% |
| Treace Medical Concepts, Inc. | 53 Million USD | 90.616% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -227.049% |
| Acutus Medical, Inc. | 32.65 Million USD | 84.766% |
| Talis Biomedical Corporation | 16.78 Million USD | 70.366% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -22.977% |
| CVRx, Inc. | 30.38 Million USD | 83.627% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -389.16% |
| Bioventus Inc. | 366.99 Million USD | 98.645% |
| Venus Concept Inc. | 70.79 Million USD | 92.973% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -299.873% |
| LivaNova PLC | 568.54 Million USD | 99.125% |
| 908 Devices Inc. | 3.92 Million USD | -26.608% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.027% |
| Nemaura Medical Inc. | 3.08 Million USD | -61.107% |
| NeuroPace, Inc. | 56.95 Million USD | 91.266% |
| LENSAR, Inc. | 1.75 Million USD | -184.252% |
| Apyx Medical Corporation | 33.18 Million USD | 85.01% |
| Cutera, Inc. | 418.69 Million USD | 98.812% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 66.934% |
| BioSig Technologies, Inc. | 103 Thousand USD | -4729.532% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 81.51% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 50.001% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.665% |
| Axonics, Inc. | 25.84 Million USD | 80.749% |
| Outset Medical, Inc. | 134.59 Million USD | 96.304% |
| IRIDEX Corporation | 1.75 Million USD | -184.09% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 90.311% |
| IRadimed Corporation | 1.61 Million USD | -207.998% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -2726.374% |
| INVO Bioscience, Inc. | 6.77 Million USD | 26.589% |
| Telesis Bio, Inc. | 5.26 Million USD | 5.591% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 16.694% |
| Varex Imaging Corporation | 464.2 Million USD | 98.928% |
| Quipt Home Medical Corp. | 60.82 Million USD | 91.821% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -745.989% |
| Pulmonx Corporation | 35.08 Million USD | 85.823% |
| Dynatronics Corporation | 3.25 Million USD | -52.661% |
| Modular Medical, Inc. | 817 Thousand USD | -508.864% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -3194.317% |
| Semler Scientific, Inc. | 70 Thousand USD | -7006.311% |
| InMode Ltd. | 6.61 Million USD | 24.778% |
| Bruker Corporation | 1.14 Billion USD | 99.565% |
| Cytosorbents Corporation | 2.54 Million USD | -95.623% |
| DexCom, Inc. | 2.57 Billion USD | 99.807% |
| Align Technology, Inc. | 96.96 Million USD | 94.87% |
| Viveve Medical, Inc. | 5.12 Million USD | 2.919% |
| ZimVie Inc. | 508.79 Million USD | 99.022% |
| Movano Inc. | 15.00 USD | -33162686.667% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 72.555% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 98.752% |
| Insulet Corporation | 1.36 Billion USD | 99.636% |
| enVVeno Medical Corporation | 1.06 Million USD | -367.52% |
| Surmodics, Inc. | 29.4 Million USD | 83.083% |
| iCAD, Inc. | 273 Thousand USD | -1722.131% |
| Nuwellis, Inc. | 221 Thousand USD | -2150.868% |
| Biotricity, Inc. | 10.85 Million USD | 54.177% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 85.767% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -665.588% |
| InspireMD, Inc. | 1.03 Million USD | -379.231% |
| PAVmed Inc. | 2.96 Million USD | -68.055% |
| BIOLASE, Inc. | 13.98 Million USD | 64.43% |
| Beyond Air, Inc. | 14.72 Million USD | 66.209% |
| FONAR Corporation | 37.92 Million USD | 86.885% |
| AxoGen, Inc. | 46.6 Million USD | 89.326% |
| Vivani Medical, Inc. | 19.31 Million USD | 74.243% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 88.85% |
| Inari Medical, Inc. | 30.35 Million USD | 83.613% |
| UFP Technologies, Inc. | 28 Million USD | 82.234% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -1046.06% |
| Tenon Medical, Inc. | 428 Thousand USD | -1062.247% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -396.449% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -131.134% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.763% |
| Sintx Technologies, Inc. | 3.68 Million USD | -34.918% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 86.636% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -745.989% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -734.634% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.442% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.017% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -719.509% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -5278.621% |
| Hyperfine, Inc. | 64 Thousand USD | -7672.528% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 97.364% |
| Biomerica, Inc. | 459 Thousand USD | -983.751% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -1006.698% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -2518.294% |
| Silk Road Medical, Inc | 75.62 Million USD | 93.422% |